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The virulence genes in invasive aspergillosis (IA) have not been analyzed adequately. The
present study was designed to evaluate the expression of gpaB and sidA genes, which are
important virulence genes in Aspergillus spp. from bronchoalveolar lavage (BAL) samples.
Direct examination and culture on Czapek Agar and Sabouraud Dextrose Agar media were
performed for 600 BAL specimens isolated from patients with possible aspergillosis. A Galac-
tomannan ELISA assay was also carried out. The expression levels of the gpaB and sidA
genes  in isolates were analyzed using quantitative real-time PCR (qRT-PCR). We  identiﬁed
2  species, including Aspergillus ﬂavus (A. ﬂavus) and Aspergillus fumigatus (A. fumigatus) in 25
positive samples for invasive aspergillosis as validated using GM-ELISA. A. ﬂavus is the main
pathogen threatening transplant recipients and cancer patients worldwide. In this study, A.
ﬂavus had low levels of the gpaB gene expression compared to A. fumigatus (p = 0.006). The
highest sidA expression was detected in transplant recipients (p = 0.05). There was no sig-
niﬁcant correlation between sidA expression and underlying disease (p = 0.15). The sidA and
gpaB gene expression patterns may provide evidence that these virulence genes play impor-
tant  roles in the pathogenicity of Aspergillus isolates; however, there are several regulatory
genes responsible for the unexpressed sidA and gpaB genes in the isolates.©  2018 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
s article under the CC BY-NC-ND license (http://creativecommons.org/an  open acceslicenses/by-nc-nd/4.0/).
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nvasive aspergillosis (IA) is a severe disease and one of the
rimary causes of mortality among immunocompromised
ndividuals, including cystic ﬁbrosis and cancer patients, as
ell as transplant recipients.1 A variety of Aspergillus  species
ct as causative agents of IA, but A. fumigatus and A. ﬂavus are
he major causes of the disease. In fact, the small size of their
onidia facilitates the entry of fungi into the alveolar cavity.2–4
f we  want to map  the gene network, which is associated with
he progression of IA in immunocompromised individuals, we
ill need detailed information related to the virulence gene
roﬁles of Aspergillus spp.
Several putative virulence factors contributing to the
athogenesis of aspergillosis,5 have been identiﬁed, including
igment production, adhesion molecules on the cell surface,
ydrolytic enzymes and toxin secretion. Additionally, it has
een proven that a network of genes is required to support
he virulence of the Aspergillus spp.6
G-proteins, involved in signal transduction pathways, and
iderophores are encoded by speciﬁc genes in the Aspergillus
enome7 and they are essential for A. fumigatus to repro-
ram its physiology in response to the environment and iron
ptake.8,9 G protein signaling and the way by which it is
egulated have been studied in a number of models in the
ast decade. Studies on the pathogenic fungi have opened
 new avenue to the concept of the regulatory mechanisms
f development, virulence/pathogenicity establishment, mat-
ng, and generation of secondary metabolites in different
ungi. Certainly, A. fumigatus G and G subunits are inevitable
or viability and vegetative growth, because gene deleted
utants are extremely defective in germination and veg-
tative growth.10 gpaB genes encode G-proteins that have
 central role in the integrity, morphogenesis, and viru-
ence of A. fumigatus,  as well as eliciting the host’s immune
esponse. A previous study demonstrated that the gpaB gene
utant strain of Aspergillus is avirulent in animal-infected IA
odels.11
In a study performed by Gehrke et al. it was shown that
eletion of two putative G-protein-coupled receptors, GprC
nd GprD, caused devastating growth defects. Furthermore,
yphal extension and germination were decreased. They
howed that the mutants strain displayed an attenuation of
irulence in a murine infection model.12
Askew and colleagues showed the gene networks with
robable roles in the integrity of the cell wall and environmen-
al change-related signaling pathways.13 Siderophore proteins
re encoded by sidA genes and play important roles in several
ital processes, including germination, oxidative stress resis-
ance, and iron storage in Aspergillus spp.9,14 Interestingly, it
as been shown that A. fumigatus exploits sidA gene expres-
ion for virulence and pathogenicity.15,16
Hissen indicated that a rescued strain of Aspergillus (Delta
idA + sidA) exhibited siderophores and had similar growth to
he wild type on Iron-limited media. In contrast to the wild-
ype and other rescued strains, it was reported that the Delta
idA strain was virulent in a mouse model of IA. It demon-
trates that sidA plays a pivotal role in the pathogenesis of
. fumigatus.15 Previous studies have already described theo l o g y 4 9 (2 0 1 8) 668–674 669
role of genes in the pathogenesis of Aspergillus.  Not only it is
not well-deﬁned which gene is exactly involved in Aspergillus
pathogenesis but also the exact function of each gene has
remained unknown.6 The expression of sidA and gpaB genes
in Aspergillus spp. was not completely deﬁned in BAL speci-
mens isolated from immunosuppressive subjects. Therefore,
regarding the importance of gpaB and sidA genes in virulence
of Aspergillus spp. either in vitro or in vivo. This study focused on
gpaB and sidA gene expressions in A. fumigatus and A. ﬂavus
for the ﬁrst time, as the primary genes involved (incriminated)
in the pathogenesis of Aspergillus spp. in BAL samples isolated
from immunocompromised and hospitalized subjects predis-
posed to developing IA.
Materials  and  methods
Patient  characteristics
Bronchoalveolar lavage (BAL) samples were collected by a
pulmonologist via bronchoscopy from 600 patients with
underlying disease and susceptible to IA between 2014 and
2015 at Masih Daneshvari Hospital, Tehran, Iran. The patient
populations include cancer patients (leukemia, liver), trans-
plant recipients (bone marrow, lung, and kidney), chronic
obstructive pulmonary disease (COPD), hemoptysis (with
an immunosuppressive condition), and allergic bronchopul-
monary aspergillosis (ABPA) patients taking corticosteroid.17
All of the participants ﬁlled informed consent. The patients’
medical records and other data, including age, gender, and
type of disease were collected and recorded in a database.
These data were kept fully anonymous. The study proto-
col was approved by the Research Ethics Committee of Iran
University of Medical Sciences (IUMS). All BAL samples were
collected twice per patient.
Specimen  culture
The BAL samples were immediately transferred to a medi-
cal mycology laboratory. The specimens were used in a direct
smear with KOH 10% and then cultured on Czapek Agar and
Sabouraud Dextrose Agar media (2% glucose, 1% peptone,
0.05% chloramphenicol, 2% agar) (Merck, Germany) for 7 days
at 25 ◦C. The growth rate of Aspergillus was checked and the
species were identiﬁed using conventional phenotyping meth-
ods such as colony colors and slide cultures.
Conﬁrmation  of  aspergillosis  using  GM-ELISA
The GM-ELISA (Platelia Aspergillus; Bio-Rad, Edmonds, WA)
was performed on positive BAL samples, according to the
manufacturer’s recommendations.18 Brieﬂy, 100 L of the
Platelia treatment solution was added to 300 L of the BAL
specimen and heated at 100 ◦C for 3 min  before undergo-
ing centrifugation. The supernatant and the horseradish
peroxidase-labeled monoclonal antibody (EBA-2) were incu-
bated at 37 ◦C in antibody-precoated microplates. The plates
were washed and then incubated with a substrate chromogen
reaction solution. The reaction was stopped by the use of
100 L of sulfuric acid and after 30 min, the optical density
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Table 1 – Sequence of primers in quantitative real-time PCR.
Gene name Sequence of primers Product size (bp) Tm (◦C) Primer efﬁciency (%)
Forward (5′→3′) Reverse (5′→3′)
sidA GCGACGATAGCCCATTTGTC ATTAGCAGGATTAGGATCAAGG 155 59 98
TCAG
CAGAgpaB CCCGACTTCCTATGACGAGC CAACGCCTATGCAT
ˇ-tubulin CGACAACGAGGCTCTGTACG CAACTTGCGCAGAT
(OD value) of each well was read using a microplate reader at
450 nm.  One well for the negative control, two wells for the cut-
off control, and one well for the positive control were used. The
results of Galactomannan ELISA assay are expressed as “galac-
tomannan index” (GMI = OD sample/mean OD cut-off control),
by comparison to the “cutoff” control. A GMI index of ≥1.0 in
two consecutive samples was considered positive.
Culture  of  Aspergillus  spp.
For RNA extraction, the Aspergillus spp. was cultured in a Yeast
Sucrose Broth (YSB) medium (Merck, Germany) at 25 ◦C for
48–72 h. The optimal growth rate was determined based on
the expansion of mycelium on the surface of the medium.
RNA  extraction,  cDNA  synthesis,  and  quantitative
real-time  PCR
RNA contents within all the samples were extracted using
the RNA-X PLUS solution (Cinaclon, cat=RN7713C-s). After dis-
rupting the Aspergillus spp. cell wall using liquid nitrogen,
the RNA-X PLUS solution was added to the sample. Chloro-
form was added after centrifugation of liquid at 2000 rpm for
5 min, the aqueous phase was transferred to a new tube. The
equal volume of isopropanol added, then the tube was cen-
trifuged at 2000 rpm for 5 min  and washed with 75% ethanol,
the semidried pellet of RNA was dissolved in DEPC treated
water. The RNA was treated with DNase (DNase I) (Invitro-
gen, Cat No 18068015) to remove genomic DNA contamination.
The quality and quantity of the extracted RNA, before and
after treatment, were examined using a gel electrophoresis
and BioPhotometer plus (Germany), respectively.
First-strand cDNA was synthesized using a high-capacity
cDNA reverse transcription kit (Hyper script reverse trans-
criptase, Gene All, Cat No 601-100), according to the
manufacturer’s protocol. The cDNA samples were kept at
−80 ◦C until being used. The expression of the gpaB and sidA
genes was quantiﬁed by real-time PCR analysis, as previously
described.19 The reactions contained 2 L of template cDNA,
0.6 L of each speciﬁc primer (10 pmol) for the sidA and gpaB
genes, 10 L of SYBR Green master mix, and 6.8 L of DEPC
water in a ﬁnal volume of 20 L. The results were normal-
ized using -tubulin ampliﬁcations run on the same plate as
the house keeping gene. The real-time PCR system was pro-
grammed to an initial denaturation and polymerase activation
for 2 min  at 95 ◦C, denaturation for 15 s at 95 ◦C, and annealing
and elongation for 1 min  at 62 ◦C over 35 cycles using a Corbet
thermo cycle (RG-6000, Australia). Speciﬁc primers for quan-
titative real-time RT-PCR were designed with online primer
design software (Genscript, Piscataway, NJ). For determination
of primers efﬁciency values, we papered the serial dilutionsCC 140 60 98
GTTGAG 200 58 99
(25 ng, 5 ng, 1 ng, 0.2 ng, 0.04 ng per microliter) of the positive
control for sidA and gapB genes. Then, the primers efﬁciency
values were determined using a Corbet thermo cycle (RG-6000,
Australia) (Table 1). The speciﬁcity of the primers was assessed
with genomic DNA from different Aspergillus species. The
standard species of A. fumigatus and A. ﬂavus (as control group)
were used in relative quantitative method using real-time PCR.
The level of sidA and gapB expressions was divided into either
down-regulation (≤mean of gene expression) or up-regulation
(>mean of gene expression), as described previously.20
Statistical  analysis
The mean of gene expression was used as the cut-off for
categorization in low and high expression groups. Relative
expression was expected using the formula 2−Ct. The
expression of the sidA and gpaB genes was normalized to
-tubulin expression. The data were analyzed using SPSS
software, version 20 (SPSS, Chicago, IL, USA). The associa-
tion between the level of gpaB and sidA expressions and
patient characteristics were explored using either Pearson’s
chi-square or Fisher’s exact test. Variations in the expression
of sidA and gpaB between immunosuppressive diseases were
assessed using the Mann–Whitney U test. A p-value of ≤0.05
was considered to be statistically signiﬁcant.
Results
Population  study
Twenty-ﬁve positive cases were detected through the
screening of 600 BAL samples received from studied patients.
The A. ﬂavus isolates were found in 17 (68%) of the cases,
and A. fumigatus isolates were also detected in 8 (32%) of the
cases. Twelve (48%) patients were male, and 13 (52%) were
female (M/F ratio = 0.92); they ranged in age from 40 to 83
years (mean = 59 and median = 60 years). The obtained results
from patient’s data showed that 9 (36%) of the patients had
COPD, while transplant recipients and cancer patients were
found in similar frequencies (24%). In addition, hemoptysis
and ABPA were detected in only 2 cases (8%) (Table 2). The
results of GM-ELISA test indicated that GM antigen was suc-
cessfully detected in the serum of the patients with positive
Aspergillus spp. in BAL samples, the result analyzed according
to GM index.
Analysis  of  gpaB  gene  expression  in  patients  and  its
correlation  with  patient  characteristics
For analysis of gpaB gene expression, ﬁrstly, the expression
level of gpaB gene in each case was normalized with -
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Table 2 – Patients’ characteristics and correlation between the levels of sidA and gpaB gene expressions (bold values are
signiﬁcant).
Patient data Total no. sidA expression (mean = 2.4) p-Value gpaB expression (mean = 33) p-Value
Low High Low High
Age (mean = 59)
≤59 14 (56) 10 (71) 4 (29)
0.54
13  (93) 1 (7)
0.17
>59 11 (44) 9 (82) 2 (18) 8 (73) 3 (27)
Gender
Male 12 (48) 9 (75) 3 (25)
0.9
10  (83) 2 (17)
0.93
Female 13 (52) 10 (77) 3 (23) 11 (85) 2 (15)
Disease
Transplant recipient 6 (24) 3 (50) 3 (50)
0.15
6  (100) 0 (0)
0.07
Cancer 6 (24) 6 (100) 0 (0) 6 (100) 0 (0)
COPDa 9 (36) 8 (89) 1 (14) 6 (67) 3 (33)
Hemoptysis 2 (8) 1 (50) 1 (50) 1 (50) 1 (50)
ABPAb 2 (8) 1 (50) 1 (50) 2 (100) 0 (0)
Aspergillus spp.
ﬂavus 17 (68) 12 (71) 5 (29)
0.28
17  (100) 0 (0)
0.006
fumigatus 8 (32) 7 (88) 1 (12) 4 (50) 4 (50)
a Chronic obstructive pulmonary disease.
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Fig. 1 – Analysis of gpaB expression levels in patients using
Mann–Whitney U test. On the basis of the standard
deﬁnitions, Box-plot shows median (bold line),
interquartile line (box), outliers (circle), and extreme
observations (star). COPD, chronic obstructive pulmonary
disease; ABPA, allergic bronco pulmonary aspergillosis.b Allergic bronco pulmonary aspergillosis.
ubulin, as housekeeping gene and the ﬁnal gene expression
evel has been calculated (2−Ct). Then, mean value of gpaB
ene expression was selected as a cut-off value to catego-
ize the level of gene expression. The mean gpaB expression
mean = 33) was chosen as a cut-off value to classify the sam-
les into two categories: each case with lower than of mean
ene level was considered as the down-regulation expression,
nd each case with higher than of mean gene level was consid-
red as the up-regulation expression. Down-regulation gpaB
xpression was found mainly in cancer patients and trans-
lant recipients; these same patients showed no instances of
p-regulation gpaB expression (Table 2).
Correlations between the level of gpaB expression and
atient characteristics were explored using either Pearson’s
hi-square or Fisher’s exact test. A signiﬁcant association was
bserved between gpaB expression and Aspergillus spp. using
sher exact test, indicating that A. ﬂavus expressed lower lev-
ls of gpaB than A. fumigatus (p = 0.006, Table 2). Moreover,
 trend became evident between decreased gpaB expression
nd underlying disease using Chi-square test (p = 0.07, Table 2).
o correlation was found between gpaB expression and other
atient characteristics, including age and gender (p = 0.17 and
 = 0.93, respectively). Among cases, a comparison of the dif-
erences between expression using the Mann–Whitney U test
emonstrated a marginal trend between cancer patients and
oth hemoptysis patients and transplant recipients (p = 0.08
nd p = 0.09, respectively). In addition, a marginal trend was
ound between transplant recipients and hemoptysis patients.
p = 0.08) (Fig. 1).
nalysis  of  sidA  gene  expression  in  patients  and  its
orrelation  with  patient  characteristics
or analysis of sidA gene expression, ﬁrstly, the expression
evel of sidA gene in each case was normalized with -tubulin, as housekeeping gene and the ﬁnal gene expression
level has been calculated (2−Ct). Then, mean value of sidA
gene expression was selected as a cut-off value to categorize
the level of gene expression. The mean of sidA expression
(mean = 2.4) was chosen as a cut-off value to classify the sam-
ples into two categories: Each case with lower than of mean
gene level was considered as the down-regulation expression,
and each case with higher than of mean gene level was consid-
ered as the up-regulation expression. Low sidA expression was
frequently observed in COPD and cancer cases (Table 2). Corre-
lations between the level of sidA expression and patient char-
acteristics were explored using either Pearson’s chi-square or
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Fig. 2 – Analysis of sidA expression levels in patients using
Mann–Whitney U test. On the basis of the standard
deﬁnitions, Box-plot shows median (bold line),
interquartile line (box), outliers (circle), and extreme
observations (star). COPD, chronic obstructive pulmonary
disease; ABPA, allergic bronco pulmonary aspergillosis.
It would be beneﬁcial for future studies to investigate sidAFisher’s exact test. Down-regulation of sidA expression was
mainly found in A. ﬂavus,  but no signiﬁcant association was
found between sidA expression and Aspergillus spp. (p = 0.28,
Table 2). Although down-regulation of sidA expression was
detected in cancer and COPD patients, no signiﬁcant corre-
lation was found between sidA expression and underlying
disease (p = 0.15). Among the patients, a comparison of the dif-
ferences between sidA expression using the Mann–Whitney
U test demonstrated a signiﬁcant difference between cancer
patients and transplant recipients (p = 0.05), and a marginal
trend between cancer patients and both hemoptysis and ABPA
patients (p = 0.08 and p = 0.08, respectively) (Table 2 and Fig. 2).
Correlation  between  Aspergillus  spp.  and  underlying
diseases
A. ﬂavus was the main pathogen in cancer patients (100%)
and transplant recipients (83%). A. ﬂavus and A. fumigatus play
similar roles in other cases, including COPD, hemoptysis, and
ABPA.
Discussion
The incidence of IA has increased in recent years in patients
with predisposing factors.21 A. fumigatus and A. ﬂavus are
known as important agents that can cause IA with enhanced
morbidity and mortality in immunocompromised patients,
such as chronic obstructive pulmonary disease (COPD) and
cancer patients, patients taking corticosteroids and antimi-
crobial prophylactic drugs, and transplant recipients.22,23 Due
to the suppressed immune systems of such individuals, the
Aspergillus conidia can pass through the alveolar epithe-
lial cells by conidiation and germination, thereby inducing
pathogenicity in patients.24,25 Furthermore, the expression of b i o l o g y 4 9 (2 0 1 8) 668–674
some Aspergillus genes has been observed to be changed with
extensive prophylaxis with ﬂuconazole, which increases the
virulence potency.26
The functions and character of the putative virulence fac-
tors of A. fumigatus are still under investigation. Although
several genes have been discovered, there are a lot of other
genes which are responsible for the regulation of virulence
gene expression. It often makes it impossible to designate
with certainty which of them contribute to the mechanism
of pathogenesis.12 Regarding the dominant role of virulence
genes in the pathogenesis of IA, there is no comprehen-
sive information concerning gene expression in Aspergillus,
although a few studies have investigated this issue in recent
years.
Our ﬁndings demonstrated the up-regulation expression
of the gpaB gene in A. fumigatus compared to A. ﬂavus.  This
may indicate that gpaB plays an essential role in the patho-
genesis of A. fumigatus.  G-proteins, as a main component
of gpaB, have been shown to have a fundamental effect
on transduction of the signals into the fungal cells.27,28 In
fact, the activation of G-protein subunits in the cell wall
of A. fumigatus increases cyclic adenosine monophosphate
(cAMP) signaling, mitogen-activated protein kinase (MAPK)
and protein kinase A (PKA) pathways in the fungi, and dele-
tion of A. fumigatus GprC and GprD genes lead to growth
destruction in all conditions, and an analysis of virulence
revealed a signiﬁcant decrease in virulence and delayed mor-
tality in a murine model of aspergillosis.12 Down-regulation
gpaB expression was detected mainly in COPD patients; the
patients exhibited no expression of this gene. This ﬁnding
is supported by the activation of other regulatory mech-
anisms, such as the MAPK signal pathway, ray proteins,
histidine kinases, calcium signaling or signal transduction by
other virulence subunits of G-proteins in the pathogenesis of
IA.29
We  observed the highest sidA gene expression in trans-
plant recipients and low expression of this gene in cancer and
COPD patients. It has been well-established that sidA plays a
crucial role in virulence due to its high-afﬁnity iron uptake sys-
tems in fungi, which triggers pathogenesis in the patients.30
Additionally, sidA genes excite Aspergillus growth in lavage
ﬂuid, also siderophore deﬁciency decreases tissue inﬂamma-
tion and invasion.31
Consistent with our ﬁnding, Gravelat et al. showed
MedA accomplishes conidiation, because in medA strain
of A. fumigatus,  bioﬁlm formation and adherence to pul-
monary epithelial, endothelial cells and ﬁbronectin have been
impaired in vitro. The medA strain also had reduced the
ability to damage pulmonary epithelial cells. Moreover, A.
fumigatus medA strain displayed low virulence in both an
invertebrate and a mammalian model of IA.32
The lack of a signiﬁcant correlation between sidA expres-
sion and underlying diseases may be related to the activation
of other systems for iron uptake by the Aspergillus species.33
The metaloreductases (MR) increased iron uptake upon the
initiation of pulmonary IA infections in animal models.34,35and gpaB gene expressions in other immunocompromised
patients, such as HIV and hepatitis patients. In summary, the
sidA and gpaB gene expression patterns in patients indicated
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hat these genes play important roles in the pathogenicity of
spergillus isolates; nevertheless, several regulatory genes and
roteins appeared to be responsible for the unexpressed sidA
nd gpaB genes in the isolates, which explain the role of this
ain mechanism.
onclusion
aken together, our ﬁndings indicated that the A. ﬂavus
as the major pathogen in cancer patients and transplant
ecipients. A high expression of gpaB in COPD samples
nd an increased expression of sidA in transplant recip-
ent may be related to the critical role of predisposing
actors in the expression of speciﬁc genes in our study
opulation.
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